8 December, 2011
The bad drug lawsuit attorneys at AvandiaRecallNews.com no longer are accepting new Avandia cases. We continue to help families affected by Zoloft birth defects.
Our lawyers are accepting and aggressively litigating nationwide Zoloft Lawsuit claims to collect damages for Zoloft birth defects.
Call us now at 800-845-6913 or click this link for Zoloft Lawsuit Information.
Let us help you and your child recover the Zoloft birth defects compensation you deserve.
Category: Avandia Cardiovascular Risk | Avandia FDA | Avandia Lawsuit | Avandia News | Avandia Recall | Avandia Safety | Avandia Senate Report | Avandia Settlements | Avandia Side Effects | Avandia Warning | Congestive Heart Failure16 October, 2011
A federal judge presiding over Avandia litigation denied drug maker GlaxoSmithKline’s motion to dismiss 60 Avandia lawsuits on statute of limitations grounds. GSK attempted to convince the judge that the claims were filed too late. Continue reading Avandia statute of limitations ruling allows new lawsuits to proceed
Category: Avandia Cardiovascular Risk | Avandia FDA | Avandia Lawsuit | Avandia News | Avandia Recall | Avandia Settlements | Avandia Side Effects17 February, 2011
The New Zealand Ministry of Health will withdraw Avandia from the market due to heart risks. The Avandia recall is scheduled for April 29. Drug regulators at the U.S. FDA have fallen short of ordering an Avandia recall. 2011 Avandia settlements have been reached in thousands of cases. Avandia lawsuits continue to be filed across the United States. Continue reading Avandia recall in New Zealand: 2011 Avandia settlements in U.S.
Category: Avandia FDA | Avandia Lawsuit | Avandia News | Avandia Recall | Avandia Settlements29 December, 2010
Drug maker GlaxoSmithKline has agreed to pay hundreds of millions of dollars to settle Avandia heart attack lawsuits. Settlement claims continue being made on new Avandia heart attack cases. Avandia lawsuit attorneys have won settlements on cases to recover financial compensation for Avandia heart attacks. Lawsuits continue to be filed against GSK on claims that diabetes drugs containing Rosigitazone caused heart attack injury and wrongful death damages. Continue reading Avandia Lawsuits Attorney for Heart Attack Injury Settlements
Category: Avandia FDA | Avandia Lawsuit | Avandia Settlements | Avandia Side Effects18 November, 2010
Since its FDA approval in 1999, Avandia heart attack, stroke, heart failure and heart related death side effects have led to safety alerts, black box warnings, and bad drug lawsuit settlements.
A timeline of events alerting diabetes patients, the FDA and Avandia lawsuit attorneys of the heart attack and other cardiovascular risks associated with the diabetes drug. Continue reading Avandia Timeline: Diabetes Drug Side Effects, FDA Warnings
Category: Avandia Cardiovascular Risk | Avandia FDA | Avandia Senate Report | Avandia Side Effects24 October, 2010
Avandia drug maker GlaxoSmithKline is under investigation by federal and state law enforcement officials, the company announced in a press release issued on October 21, 2010:
[GSK] is in the process of responding to a US Department of Justice (DOJ) subpoena relating to the development and marketing of Avandia. Continue reading GSK under state, federal criminal investigations of Avandia
Category: Avandia FDA | Avandia Lawsuit | Avandia News | Avandia Recall | Avandia Settlements15 October, 2010
A FDA Avandia news conference was held on September 23, 2010 to announce the FDA decision on Avandia and for FDA drug safety officials to take questions from the media.
The following is a complete transcript of the news conference. FDA Commissioner Margaret Hamburg, FDA Principal Deputy Commissioner Joshua Sharfstein and Janet Woodcock, Director of the Center for Drug Evaluation and Research at FDA all were in attendance. Continue reading FDA Avandia news conference: 2010 rosiglitazone restrictions
Category: Avandia Cardiovascular Risk | Avandia FDA | Avandia News | Avandia Recall | Avandia Safety | Avandia Warning8 October, 2010
In May 2007, Cleveland Clinic cardiologist Dr. Steven Nissen published an Avandia study in the New England Journal of Medicine that would mark a turning point for the diabetes drug Avandia.
Dr. Nissen found that Avandia use was linked to a 43% increased risk of heart attack. and has been a vocal critic of Avandia ever since. Dr. Nissen reacts to the September 23, 2010 FDA Avandia restrictions. Continue reading FDA Avandia heart attack news, Avandia critic reacts to FDA
Category: Avandia Cardiovascular Risk | Avandia FDA | Avandia News | Avandia Safety | Avandia Settlements | Avandia Warning30 September, 2010
Last week, an Avandia recall in Europe was announced as the FDA put tight new restrictions on Avandia use in the United States.
Avandia has been on the market in the U.S. to treat type 2 diabetes since 1999. How long have drug maker GlaxoSmithKline and the FDA been aware of Avandia side effects risks? According to a lead Senate investigator, the answer is shocking. Continue reading Avandia Recall News: GSK hid Rosiglitazone side effects risks
Category: Avandia FDA | Avandia Lawsuit | Avandia News | Avandia Senate Report | Avandia Settlements | Avandia Side Effects25 September, 2010
FDA stops Avandia TIDE trial due to unjustified risk of stroke and cardiac events.
Act now to make you Avandia settlement claim. FDA drug safety experts concluded that the TIDE trial subjected participants to an unjustified risk of heart disease. All of the regulatory deadlines set by the FDA for completion of the trial have been rescinded. Continue reading FDA stops Avandia TIDE trial due to unjustified heart risks
Category: Avandia Cardiovascular Risk | Avandia FDA | Avandia News | Avandia Safety